# A Study of Xenical (Orlistat) in Overweight and Obese Adolescents

> **NCT00940628** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 60 (actual)

## Conditions studied

- Obesity

## Interventions

- **BEHAVIORAL:** Diet and Exercise
- **DRUG:** orlistat [Xenical]

## Key facts

- **NCT ID:** NCT00940628
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00940628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00940628, "A Study of Xenical (Orlistat) in Overweight and Obese Adolescents". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00940628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*